Long-Term Survival Following Endoscopic and Surgical Treatment of High-Grade Dysplasia in Barrett's Esophagus

Gastroenterology

Volumn 132, Issue 4, 2007, Pages 1226-1233

  Prasad, Ganapathy A ^a   Wang, Kenneth K ^a   Buttar, Navtej S ^a   Wongkeesong, Louis Michel ^a   Krishnadath, Kausilia K ^c   Nichols III, Francis C ^b   Lutzke, Lori S ^a   Borkenhagen, Lynn S ^a  

^a MAYO CLINIC   (United States)

^b Mayo Clinic   (United States)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BENATOPRAZOLE; HEMATOPORPHYRIN DERIVATIVE; PHOTOFRIN; PHOTOSENSITIZING AGENT;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; BLISTER; CANCER INVASION; DIAPHRAGM; DYSPLASIA; ENDOSCOPIC MUCOSAL RESECTION; ENDOSCOPIC SURGERY; ERYTHEMA; ESOPHAGUS RESECTION; ESOPHAGUS STRICTURE; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HIGH GRADE DYSPLASIA; HUMAN; INTERNET; KAPLAN MEIER METHOD; LIGHT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVERALL SURVIVAL; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RANK SUM TEST; STATISTICAL ANALYSIS; SURGEON; SURGICAL APPROACH; SURGICAL TECHNIQUE; SURVIVAL TIME; THORACIC CAVITY; TREATMENT OUTCOME; VITAL SIGN;

EID: 34247263209     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.02.017     Document Type: Article

References (43)

1. Spechler S.J. Clinical practice. Barrett's esophagus. N Engl J Med 346 (2002) 836-842
2. Cameron A.J., Ott B.J., and Payne W.S. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 313 (1985) 857-859
3. Buttar N.S., Wang K.K., Sebo T.J., Riehle D.M., Krishnadath K.K., Lutzke L.S., Anderson M.A., Petterson T.M., and Burgart L.J. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology 120 (2001) 1630-1639
4. Cameron A.J., and Carpenter H.A. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Am J Gastroenterol 92 (1997) 586-591
5. Edwards M.J., Gable D.R., Lentsch A.B., and Richardson J.D. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia. Ann Surg 223 (1996) 585-589 ; discussion 589-591
6. Ell C., May A., Gossner L., Pech O., Gunter E., Mayer G., Henrich R., Vieth M., Muller H., Seitz G., and Stolte M. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 118 (2000) 670-677
7. Heitmiller R.F., Redmond M., and Hamilton S.R. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann Surg 224 (1996) 66-71
8. Heitmiller R.F. Prophylactic esophagectomy in Barrett esophagus with high-grade dysplasia. Langenbecks Arch Surg 388 (2003) 83-87
9. Shaheen N.J., Inadomi J.M., Overholt B.F., and Sharma P. What is the best management strategy for high grade dysplasia in Barrett's oesophagus?. A cost effectiveness analysis. Gut 53 (2004) 1736-1744
10. Schnell T.G., Sontag S.J., Chejfec G., Aranha G., Metz A., O'Connell S., Seidel U.J., and Sonnenberg A. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 120 (2001) 1607-1619
11. Weston A.P., Badr A.S., and Hassanein R.S. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma. Am J Gastroenterol 94 (1999) 3413-3419
12. Weston A.P., Sharma P., Topalovski M., Richards R., Cherian R., and Dixon A. Long-term follow-up of Barrett's high-grade dysplasia. Am J Gastroenterol 95 (2000) 1888-1893
13. Chang L.C., Oelschlager B.K., Quiroga E., Parra J.D., Mulligan M., Wood D.E., and Pellegrini C.A. Long-term outcome of esophagectomy for high-grade dysplasia or cancer found during surveillance for Barrett's esophagus. J Gastrointest Surg 10 (2006) 341-346
14. DeMeester S.R. Endoscopic mucosal resection and vagal-sparing esophagectomy for high-grade dysplasia and adenocarcinoma of the esophagus. Semin Thorac Cardiovasc Surg 17 (2005) 320-325
15. Fernando H.C., Luketich J.D., Buenaventura P.O., Perry Y., and Christie N.A. Outcomes of minimally invasive esophagectomy (MIE) for high-grade dysplasia of the esophagus. Eur J Cardiothorac Surg 22 (2002) 1-6
16. Luketich J.D., Nguyen N.T., and Schauer P.R. Laparoscopic transhiatal esophagectomy for Barrett's esophagus with high grade dysplasia. JSLS 2 (1998) 75-77
17. Pera M., Trastek V.F., Carpenter H.A., Allen M.S., Deschamps C., and Pairolero P.C. Barrett's esophagus with high-grade dysplasia: an indication for esophagectomy?. Ann Thorac Surg 54 (1992) 199-204
18. Rice T.W., Falk G.W., Achkar E., and Petras R.E. Surgical management of high-grade dysplasia in Barrett's esophagus. Am J Gastroenterol 88 (1993) 1832-1836
19. Sujendran V., Sica G., Warren B., and Maynard N. Oesophagectomy remains the gold standard for treatment of high-grade dysplasia in Barrett's oesophagus. Eur J Cardiothorac Surg 28 (2005) 763-766
20. Headrick J.R., Nichols III F.C., Miller D.L., Allen M.S., Trastek V.F., Deschamps C., Schleck C.D., Thompson A.M., and Pairolero P.C. High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy. Ann Thorac Surg 73 (2002) 1697-1702 ; discussion 1702-1703
21. Conio M., Repici A., Cestari R., Blanchi S., Lapertosa G., Missale G., Della Casa D., Villanacci V., Calandri P.G., and Filiberti R. Endoscopic mucosal resection for high-grade dysplasia and intramucosal carcinoma in Barrett's esophagus: an Italian experience. World J Gastroenterol 11 (2005) 6650-6655
22. Prasad G.A., Wang K.K., Lutzke L.S., Lewis J.T., Sanderson S.O., Buttar N.S., Wong Kee Song L.M., Borkenhagen L.S., and Burgart L.J. Frozen section analysis of esophageal endoscopic mucosal resection specimens in the real-time management of Barrett's esophagus. Clin Gastroenterol Hepatol 4 (2006) 173-178
23. D'Agostino Jr. R.B. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17 (1998) 2265-2281
24. Haynes S.R., and Lawler P.G. An assessment of the consistency of ASA physical status classification allocation. Anaesthesia 50 (1995) 195-199
25. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373-383
26. Hall W.H., Ramachandran R., Narayan S., Jani A.B., and Vijayakumar S. An electronic application for rapidly calculating Charlson comorbidity score. BMC Cancer 4 (2004) 94
27. Prasad G.A., Wang K.K., Buttar N.S., Wongkeesong L.M., Lutzke L.S., and Borkenhagen L.S. Predictors of stricture formation after photodynamic therapy for high-grade dysplasia in Barrett's esophagus. Gastrointest Endosc 65 (2007) 60-66
28. Ronkainen J., Aro P., Storskrubb T., Johansson S.E., Lind T., Bolling-Sternevald E., Vieth M., Stolte M., Talley N.J., and Agreus L. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 129 (2005) 1825-1831
29. Miros M., Kerlin P., and Walker N. Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus. Gut 32 (1991) 1441-1446
30. Reid B.J., Levine D.S., Longton G., Blount P.L., and Rabinovitch P.S. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. Am J Gastroenterol 95 (2000) 1669-1676
31. Drewitz D.J., Sampliner R.E., and Garewal H.S. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 92 (1997) 212-215
32. O'Connor J.B., Falk G.W., and Richter J.E. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. Am J Gastroenterol 94 (1999) 2037-2042
33. Shaheen N.J., Crosby M.A., Bozymski E.M., and Sandler R.S. Is there publication bias in the reporting of cancer risk in Barrett's esophagus?. Gastroenterology 119 (2000) 333-338
34. Falk G.W. Barrett's esophagus-is it bad for your health?. Am J Gastroenterol 100 (2005) 2622-2623
35. Eckardt V.F., Kanzler G., and Bernhard G. Life expectancy and cancer risk in patients with Barrett's esophagus: a prospective controlled investigation. Am J Med 111 (2001) 33-37
36. Anderson L.A., Murray L.J., Murphy S.J., Fitzpatrick D.A., Johnston B.T., Watson R.G., McCarron P., and Gavin A.T. Mortality in Barrett's oesophagus: results from a population based study. Gut 52 (2003) 1081-1084
37. Solaymani-Dodaran M., Logan R.F., West J., and Card T. Mortality associated with Barrett's esophagus and gastroesophageal reflux disease diagnoses-a population-based cohort study. Am J Gastroenterol 100 (2005) 2616-2621
38. Reed M.F., Tolis Jr. G., Edil B.H., Allan J.S., Donahue D.M., Gaissert H.A., Moncure A.C., Wain J.C., Wright C.D., and Mathisen D.J. Surgical treatment of esophageal high-grade dysplasia. Ann Thorac Surg 79 (2005) 1110-1115
39. Pech O., Gossner L., May A., Rabenstein T., Vieth M., Stolte M., Berres M., and Ell C. Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia. Gastrointest Endosc 62 (2005) 24-30
40. Overholt B.F., Lightdale C.J., Wang K.K., Canto M.I., Burdick S., Haggitt R.C., Bronner M.P., Taylor S.L., Grace M.G., and Depot M. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc 62 (2005) 488-498
41. Prasad G.A., Wang K.K., Buttar N.S., Wongkeesong L.M., Papenfuss S.M., and Lutzke L. Evaluation of Barrett's esophagus with EUS and EMR. Am J Gastroenterol 99 (2004) AB 82
42. Birkmeyer J.D., Siewers A.E., Finlayson E.V., Stukel T.A., Lucas F.L., Batista I., Welch H.G., and Wennberg D.E. Hospital volume and surgical mortality in the United States. N Engl J Med 346 (2002) 1128-1137
43. Overholt B.F., Panjehpour M., and Halberg D.L. Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results. Gastrointest Endosc 58 (2003) 183-188